Benchling, a San Francisco, CA-based life science R&D software company, raised $7m in funding.
The round was led by Thrive Capital with participation from Andreessen Horowitz, Y Combinator partner Geoff Ralston, Sequoia partner Matt Huang, CXO of Tencent David Wallerstein, and actor/tech investor Ashton Kutcher.
The company, which has now raised over $13m, plans to use the funds to expand scientific operations, broaden development across more therapeutic areas, and further expand its platform.
Founded in 2012 by Sajith Wickramasekara, CEO, Benchling provides an integrated cloud-based software platform consisting of lab notebook, LIMS, and molecular biology tools to over 40,000 academic and industry scientists, who represent more than 10,000 academic institutions and over 150 companies.
In the coming quarter, the company plans to release a product that bridges structured and unstructured scientific data.